ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

ClinicalTrials.gov ID: NCT05593497

Public ClinicalTrials.gov record NCT05593497. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 10:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Precision Neoadjuvant Therapy for High Risk Localized Prostate Cancer With PTEN Loss

Study identification

NCT ID
NCT05593497
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
VA Office of Research and Development
Federal
Enrollment
30 participants

Conditions and interventions

Interventions

  • Capivasertib Drug
  • abiraterone acetate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 30, 2024
Primary completion
Apr 30, 2027
Completion
Jul 31, 2027
Last update posted
Mar 26, 2026

2024 – 2027

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
VA Greater Los Angeles Healthcare System, West Los Angeles, CA West Los Angeles California 90073-1003 Recruiting
James J. Peters VA Medical Center, Bronx, NY The Bronx New York 10468-3904 Recruiting
VA Portland Health Care System, Portland, OR Portland Oregon 97207-2964 Recruiting
Ralph H. Johnson VA Medical Center, Charleston, SC Charleston South Carolina 29401-5703 Recruiting
South Texas Health Care System, San Antonio, TX San Antonio Texas 78229-4404 Terminated
VA Puget Sound Health Care System Seattle Division, Seattle, WA Seattle Washington 98108-1532 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05593497, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 26, 2026 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05593497 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →